It is currently Tue Jul 22, 2014 4:50 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Drug for control over emotions

The approval for a drug for MS sufferers who can't control their emotions has been delayed - not surprising that we can't control our emotions given that the drugs they create are either ineffective, kill, or are subject to delays!

http://c.moreover.com/click/here.pl?j395717806&w=464753
Read more : Drug for control over emotions | Views : 1328 | Replies : 0


Cannaboids

The following research paper suggests that cannaboids are useful in relation to neuro-degenerative / inflammatory diseases.


http://c.moreover.com/click/here.pl?j395340532&w=464753


The UK are funding some large scale trials into cannaboids as there is some evidence that they may ahve a neuro-protective effect -

Clinical Trials of cannabinoids as neuroprotective agents in MS
Professor John Zajicek, from the Peninsula Medical School in Plymouth, outlined the reasons for believing that some cannabinoids (chemicals derived ...
Read more : Cannaboids | Views : 2051 | Replies : 0


Just incase we missed something

Clinical Trials In Multiple Sclerosis 2005:

Sorry having a hard time entering this link so try getting there through google. Second one down on google link


<shortened url>
Read more : Just incase we missed something | Views : 1542 | Replies : 2


Drug for ALS

This is an early trial for a drug for ALS but could also be of benefit to MS.

Bromley

http://c.moreover.com/click/here.pl?j388933782&w=464753
Read more : Drug for ALS | Views : 1423 | Replies : 0


Another drugs comany involved in MS treatments

Another drugs company expanding into MS treatments


http://www.multicelltech.com/news/press_090705.htm

Bromley
Read more : Another drugs comany involved in MS treatments | Views : 1220 | Replies : 0


vasoactive intestinal peptide

Another t-reg experimental therapy...



Spanish scientists develop a cellular therapy for rheumatoid arthritis and multiple sclerosis

2005-09-09 -- A research team at the Institute of Parasitology and Biomedicine of the Spanish National Research Council (CSIC), in Grenade, has successfully developed in mice a cellular therapy for two major autoimmune diseases: rheumatoid arthritis and multiple sclerosis. The scientists succeeded, in both experimental models, in making the symptoms disappear and inducing a reversion of the degenerative process. ...
Read more : vasoactive intestinal peptide | Views : 1517 | Replies : 2


Neurovax

Dear all,

Not sure if this article has been posted before- it's about Neurovax and the experience of one triallist. Looks promising (like Tovaxin) - but don't they all! Probably a few years before it reaches thr market (if the trials are successful).

http://c.moreover.com/click/here.pl?j386259827&w=464753


Bromley

PS Apologies Dignan had already posted on this earlier. It was on the NZ MS site today so I assumed it was new news!
Read more : Neurovax | Views : 1599 | Replies : 0


Riluzole completed Phase I for PPMS

The Accelerated Cure project mentioned this small Phase I trial in their news section today. Riluzole is a drug for ALS. It's always good news when they test a drug for PPMS.



Glutamate inhibition in MS: the neuroprotective properties of riluzole

J Neurol Sci. 2005 Jun 15;233(1-2):113-5. Epub 2005 Apr 20.

Killestein J, Kalkers NF, Polman CH.
Department of Neurology, VU Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands. J.Killestein@vumc.nl ...
Read more : Riluzole completed Phase I for PPMS | Views : 1433 | Replies : 1


Cannabinor in Phase I trials

I guess I jumped the gun on my pipeline list a bit as I already had this in Phase I.



Pharmos Initiates Phase I Trial of CB2-Selective Drug Candidate Cannabinor

Sept. 6 -- PRNewswire-FirstCall -- Pharmos Corporation announced today that it has initiated a Phase I trial with cannabinor, a CB2-selective synthetic cannabinoid drug candidate. The study will assess the safety, tolerability and pharmacokinetics of cannabinor in healthy volunteers.

The trial will enroll up to ...
Read more : Cannabinor in Phase I trials | Views : 1236 | Replies : 0


Article about MN-166 Phase II trial

This is one that's been talked about before, but here is a new article.



Doctors to Test Stroke Drug for MS

09-02-05 - A medication currently available in Southeast Asia to treat asthma and vascular disorders in the brain is now undergoing clinical testing as a possible therapy for multiple sclerosis. The drug is known as Ketas® (ibudilast) in Japan and Korea. But it uses a code name, MN-166, in its current clinical scrutiny as ...
Read more : Article about MN-166 Phase II trial | Views : 1409 | Replies : 0


 

Login  •  Register


Statistics

Total posts 218637 • Total topics 22526 • Total members 14173